
Yes
Clomiphene Citrate
Female Infertility
Clomiphene triggers the brain’s pituitary gland to secrete an increased amount of follicle stimulating hormone (FSH) and LH (luteinizing hormone). This action stimulates the growth of the ovarian follicle and thus initiates ovulation.
Treatment of the selected patient should begin with a low dose, 50 mg daily (1 tablet) for 5 days. The dose should be increased only in those patients who do not ovulate in response to cyclic 50 mg Ovan (Clomifene Citrate). Consult your doctor or pharmacist for dose adjustments.
Fever, tinnitus, weakness , Arrhythmia, chest pain, edema, hypertension, palpitation, phlebitis, pulmonary embolism, shortness of breath, tachycardia, thrombophlebitis , Migraine headache, paresthesia, seizure, stroke, syncope , Acne, allergic reaction, erythema, erythema multiforme, erythema nodosum, hypertrichosis, pruritus, urticaria , amelia, hemimelia, and phocomelia), foot (clubfoot), spine, and joints , Arthralgia, back pain, myalgia.
Danazol , oestradiol.
It is used for some types of infertility, in women who are not ovulating properly.
Clomifene is contraindicated in patients with a known hypersensitivity or allergy to Clomifene or to any of its ingredients.Clomifene therapy is contraindicated in patients with liver disease or a history of liver dysfunction.
Clomifene Citrate use in pregnant women is contraindicated, as Clomifene treatment does not oer benet in this population.
Patients should be advised that blurring or other visual symptoms such as spots or ashes (scintillating scotomata) may occasionally occur during therapy with Clomifen .
Clomifene therapy usually regresses spontaneously within a few days or weeks after discontinuing treatment.
The ovarian hyperstimulation syndrome (OHSS) may occur in patients receiving Clomifene therapy for ovulation induction.
Always consult your physician before using any medicine.
Store this medicine at room temperature, away from direct light and heat.
You must be logged in to post a review.
Reviews
There are no reviews yet.